TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Steroid shots linked to fatal meningitis, CDC says

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

By The Associated Press
Wednesday, Oct. 3, 2012, 7:45 p.m.
 

NASHVILLE — An outbreak of a rare and deadly form of meningitis has sickened 26 people in five states who received steroid injections, said health officials on Wednesday. Four people have died.

Eighteen of the cases are in Tennessee, where a Nashville clinic received the largest shipment of the steroid suspected in the outbreak. The drug — commonly prescribed for back pain —was manufactured by New England Compounding Center in Massachusetts, which has issued a recall.

Three cases have been reported in Virginia, two in Maryland, two in Florida and one in North Carolina. Two of the deaths were in Tennessee; Virginia and Maryland had one each, said the Centers for Disease Control and Prevention.

More cases are expected to surface, said Tennessee Department of Health.

Investigators have been looking into at least three products used for the back injections that could have been tainted by the fungus that appears to be behind the illnesses.

None of the products have been ruled out, they said.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. Federal Reserve Vice Chairman Fischer open to interest rate hike
  2. Clinton: Women ‘expect’ extremism from terrorists, not GOP candidates
  3. Will Trump run as independent? He says decision will be made soon
  4. Court lifts injunction against NSA call records program
  5. New Orleans slow to heal 10 years after Hurricane Katrina
  6. Thousands in New Orleans became targets of unscrupulous contractors
  7. Kraft Heinz recalls more than 2M pounds of turkey bacon
  8. TSA agent accused of sex abuse at LaGuardia Airport
  9. Obama opens climate change tour
  10. Man arrested in deputy’s ambush
  11. Iran nuclear deal picks up support in Senate